Year: 2020
Type: article
Abstract: Summary Preclinical and epidemiological evidence suggests that vitamin D may have anti-cancer activities in patients with colorectal cancer. A recently completed, randomised Phase 2 trial of vitamin D3 supplementation in patients with metastatic colorectal cancer has shown promising results, and a Phase 3 trial is currently underway.
Source: British Journal of Cancer
Authors: Chen Yuan, Kimmie Ng
Institutions: Harvard University, Dana-Farber Cancer Institute
Language: English
Topic: Vitamin D Research Studies
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,300
Awards: Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer, Dietary And Lifestyle Determinants Of Colon Cancer Recurrence and Survival, Leveraging Novel Randomized Clinical Trials of Vitamin D Supplementation in Patients with Colorectal Cancer: Impact on Survival and Anti-Tumor Immunity
OpenAlex ID: W3040391072